Difference in changes in ODI and EQ-5D-5L scores among three groups (n = 45). by Jae-Hong Kim (124622)

Subjects:

Changes in outcome measures after treatment completion in the three groups. by Jae-Hong Kim (124622)

Subjects:

Homogeneity tests for baseline demographic characteristics and study variables for 45 patients with chronic non-specific low back pain. by Jae-Hong Kim (124622)

Subjects:

Changes in vital signs (Week4 vs. Week0) after treatment completion within the three groups. by Jae-Hong Kim (124622)

Subjects:

CONSORT 2010 flow diagram. by Jae-Hong Kim (124622)

Subjects:

Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) statement. by Jae-Hong Kim (124622)

Subjects:

Difference in changes in vital signs (Week4 vs. Week0) among three groups. by Jae-Hong Kim (124622)

Subjects:

Difference in changes in VAS scores among three groups (n = 45). by Jae-Hong Kim (124622)

Subjects:

Repeated Topical Administration of 3 nm Cerium Oxide Nanoparticles Reverts Disease Atrophic Phenotype and Arrests Neovascular Degeneration in AMD Mouse Models by Anna Badia (14322814)

Repeated Topical Administration of 3 nm Cerium Oxide Nanoparticles Reverts Disease Atrophic Phenotype and Arrests Neovascular Degeneration in AMD Mouse Models by Anna Badia (14322814)

750N of vertical load on the femur; 750N of vertical load on the femur, combined with 105N of anterior tibial load; 750N of vertical load on the femur, combined with 7.5Nm of tibia... by Deyan Ou (18143912)

Coefficient of Variation (%), Peak Torque (N.m), Muscle Activation (%MVIC) and Co-Contraction Index of the analysed muscles in the three conditions: Control, external, internal. by Philipp Bauer (21601393)

No change was observed in Caco-2 cell number, as measured by crystal violet absorbance, after treatment with 100nM M64HCl for 24 hours in a standard cell culture medium. by Sema Oncel (10152053)

Subjects:

Fluorescent intensity at 520 nm (RNase A/B) and 556 nm (DNase I) versus time for nucleases in DI water lysed with Lyse-It at 30% and 50% power for varying time. by Tonya M. Santaus (5559077)

“…<b>(A)</b> 20 pM RNase A <b>(B)</b> 46 pM RNase B, <b>(C)</b> 10.5 nM DNase I. As microwave power and time increase, nuclease activity decreases.…”

Secondary structure profile analysis for the SP domain of native PC and its mutant structures over 200 ns MD simulation times. by Mahvash Farajzadeh-Dehkordi (17468232)

Principal component analysis (PCA) for the SP domain of native PC and its mutant structures over 200 ns MD simulation times. by Mahvash Farajzadeh-Dehkordi (17468232)

The capture efficiency of BioMagnetic solutions FerroSelect in PBS/1% BSA and whole blood showed a decrease in capture efficiency when moving to whole blood. by Peng Liu (120506)

Mechanical Properties of Ultrathin Polystyrene‑<i>b</i>‑Polybutadiene‑<i>b</i>‑Polystyrene Block Copolymer Films: Film Thickness-Dependent Young’s Modulus by Masayuki Saito (205833)

2‑Aminobenzoxazole Derivatives as Potent Inhibitors of the Sphingosine-1-Phosphate Transporter Spinster Homolog 2 (Spns2) by Ariel L. Burgio (15069256)

“…To develop more potent compounds, we initiated a structure–activity relationship study that identified 2-aminobenzoxazole as a viable scaffold. …”

Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3‑Oxo-3,4-dihydro‑2<i>H</i>‑ben... by Shuhei Ikeda (2380180)

“…Optimization of the left hand side afforded <b>4f</b> as a promising reversible MAGL inhibitor, which showed potent in vitro MAGL inhibitory activity (IC₅₀ 6.2 nM), good oral absorption, blood–brain barrier penetration, and significant pharmacodynamic changes (2-arachidonoylglycerol increase and arachidonic acid decrease) at 0.3–10 mg/kg, po. in mice.…”